All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 204 of 206 pages ‹ First < 202 203 204 205 206 >
HSL19658
Angell M
A epidemia de doença mental
Edição 59 2011
http://revistapiaui.estadao.com.br/edicao-59/questoes-medico-farmacologicas/a-epidemia-de-doenca-mental
HSL19666
Ariely D
Dan Ariely: Beware conflicts of interest
TED.com 2011 Aug
http://www.ted.com/talks/dan_ariely_beware_conflicts_of_interest.html?awesm=on.ted.com_9daV#.TmSznHlzNTQ.facebook
HSL19680
Henrique Prezzi S
Drotrecogina na Sepse - Contraponto
Medicina Hospitalar 2007
http://www.medicinahospitalar.com.br/Aulas/ContrapontoDotrecogina/Drotrecogina_files/intro.htm
HSL19684
Moynihan R.
Payments to doctors in Australia are to be scrutinised after marketing tactics are exposed.
BMJ 2011 18;343:d6714:
doi: 10.1136/bmj.d6714. No abstract available.
http://www.bmj.com/content/343/bmj.d6714.long
HSL19685
Moynihan R.
Is journalism the drug industry's new dance partner?
BMJ 2011 2;343:d6978:
doi: 10.1136/bmj.d6978. No abstract available.
http://www.bmj.com/content/343/bmj.d6978.long
HSL19700
Australian Government
TGA reforms: A blueprint for TGA’s future
2011 Dec
http://www.tga.gov.au/pdf/media-2011-tga-reforms-111208.pdf
HSL19701
Schofferman J.
The medical-industrial complex, professional medical associations, and continuing medical education.
Pain Med 2011;12:(12):1713-9
doi: 10.1111/j.1526-4637.2011.01282.x. Epub 2011 Dec 6.
http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2011.01282.x/abstract;jsessionid=2442C14B5DA9F2C8FEA0ACD80B235B3B.d02t02
HSL19710
Ben Goldacre: Combatendo ciência ruim
TED.com 2011 Sep0
http://www.ted.com/talks/lang/pt-br/ben_goldacre_battling_bad_science.html
HSL19721
Moskop JC, Iserson KV, Aswegan AL, Larkin GL, Schears RM.
Gifts to Physicians From Industry: The Debate Evolves.
Ann Emerg Med 2011 27;
http://www.sciencedirect.com/science/article/pii/S0196064411014120
HSL19722
Jutel A, Menkes DB.
'But doctors do it...': nurses' views of gifts and information from the pharmaceutical industry
Ann Pharmacother. 2009;43:(6):1057-63
http://www.theannals.com/content/43/6/1057.long
HSL19723
Rodwin MA.
Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
J Law Med Ethics 2011;39:(4):662-70
doi: 10.1111/j.1748-720X.2011.00633.x.
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2011.00633.x/abstract;jsessionid=87F44D2C068F3A098926CD3CA202E752.d04t03
HSL19739
Manchanda P, Wittink Dr, Ching A, Cleanthous P, Ding M, Dong XJ, Leeflang PSH, Misra S, Mizik N, Narayanan S, Steenburgh T, Wieringa JE, Wosinska M, Xie Y,
Understanding Firm, Physician and Consumer Choice Behaviour in the Health Care Industry
Sixth Invitational Choice Symposium hosted by the University of Colorado 2004 Sep
www.springerlink.com/index/518wvx08320847g5.pdf
HSL19743
Pieters T.
About media, audiences and marketing medicines: the interferons.
Clio Med 2002;66:229-43:
http://www.ncbi.nlm.nih.gov/pubmed/12028679
HSL19744
Jones J
Medical Publishing: Part 3
PMLive.com 2002
HSL19745
Ed.
Drug promotion: stealth, wealth, and safety.
Lancet 1993 12;341:(8859):1507-8
http://www.sciencedirect.com/science/article/pii/014067369390637V
HSL19750
Rosenberg CE.
The tyranny of diagnosis: specific entities and individual experience.
Milbank Q 2002;80:(2):237-60
http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.t01-1-00003/abstract;jsessionid=5B9815EFE8B821B590EAA5D146EE29DB.d01t02?systemMessage=Wiley+Online+Library+will+be+disrupted+14+Jan+from+10-12+GMT+for+monthly+maintenance
HSL19751
Greenhalgh T.
Beware cloth devils.
BMJ 2000 8;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127742/?tool=pubmed
HSL19752
Flower R.
Lifestyle drugs: pharmacology and the social agenda.
Trends Pharmacol Sci 2004;25:(4):182-5
http://www.sciencedirect.com/science/article/pii/S0165614704000549
HSL19755
Lexchin J.
Lifestyle drugs: issues for debate.
CMAJ 2001 15;164:(10):1449-51
http://www.cmaj.ca/content/164/10/1449.long
HSL19756
Starcevic V.
Opportunistic 'Rediscovery' of mental disorders by the pharmaceutical industry.
Psychother Psychosom 2002;71:(6):305-10
http://content.karger.com/produktedb/produkte.asp?DOI=65989&typ=pdf
HSL19759
Villanueva P, Peiró S, Librero J, Pereiró I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 4;361:(9351):27-32
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2803%2912118-6/fulltext
HSL19779
Wolfsthal SD, Beasley BW, Kopelman R, Stickley W, Gabryel T, Kahn MJ; Membership Survey and Scientific Data Committee, The Association of Program Directors of Internal Medicine.
Benchmarks of support in internal medicine residency training programs.
Acad Med 2002;77:(1):50-6
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=PWVKtY1YDSjYJptRs49jD2dLTnsMb4S3HdnYYvvfJLdw2hQRJG1H!-1165837873!181195629!8091!-1?issn=1040-2446&volume=77&issue=1&spage=50
HSL19795
Huston P, Moher D.
Redundancy, disaggregation, and the integrity of medical research.
Lancet 1996 13;347:(9007):1024-6
http://www.ncbi.nlm.nih.gov/pubmed/8606568
HSL19798
Wilmshurst P.
Publication bias.
Lancet 1991 8;337:(8754):1419
http://www.sciencedirect.com/science/article/pii/014067369193110U
HSL19811
Durand M
Reality Check: Is It Newsworthy?
Pharma Exec 2003 Apr
pharmexec.findpharma.com/
HSL19832
AMSA move on code
Australian Medicine 2004 May 174
HSL19833
Abraham J.
Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK.
Soc Sci Med 2002;55:(9):1671-90
http://linkinghub.elsevier.com/retrieve/pii/S0277953602001600
HSL19835
Brotzman GL, Mark DH.
The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.
J Gen Intern Med 1993;8:(3):130-4
http://www.ncbi.nlm.nih.gov/pubmed/8455108
HSL19847
Taylor B.
Giveaway drugs: good intentions, bad design.
Health Aff (Millwood) 2004;23:(1):213-7
http://content.healthaffairs.org/content/23/1/213.long
HSL19850
Finaly L
Just Like a Woman
Fashion Date uncertain 200477-78
HSL19853
Chapman S
Not biting the hand that feeds you. Tobacco advertising and editorial bias in Australian newspapers.
MJA 1984 14;480
http://www.ncbi.nlm.nih.gov/pubmed/6708868
HSL19854
Pharmaceutical sponsorship of practice newsletters called into question
Medical Forum 2002 Dec10
HSL19855
McNeil JJ, Grabsch EA, McDonald MM
Postmarketing surveillance: strengths and limitations.The flucloxacillin-dicloxacillin story.
Med J Aust. 1999 Mar 15;170:(60):270-3
http://www.ncbi.nlm.nih.gov/pubmed/10212650
HSL19861
Stauber J, Rampton S
The Public Relations Industry's Secret War on Activists
Covert Action Quarterly 1995
http://mediafilter.org/caq/Caq55.prwar.html
HSL19862
Caudill TS, Johnson MS, Rich EC, McKinney WP.
Physicians, pharmaceutical sales representatives, and the cost of prescribing.
Arch Fam Med 1996;5:(4):201-6
http://www.ncbi.nlm.nih.gov/pubmed/8769907
HSL19863
Wenley S
Free drug offer puts pressure on GPs to prescribe
GP Date uncertain Before 2000 4
HSL19872
Meyers D.
Doctors, research funds and marketing.
Med J Aust 1995 3;162:(7):392
http://www.ncbi.nlm.nih.gov/pubmed/7715534
HSL19873
Mansfield P
Pushing expensive new drugs
Consuming Interest 2001 00 00;
HSL19874
Mansfield P
Pushing expensive new drugs
Consuming Interest 20010
HSL19875
Cassels A
Donuts for doctors: Buying the medical profession
Common Ground 2005 Sep
http://www.commonground.ca/iss/0509170/cg170_donuts.shtml
HSL19876
Cialdini RB
The Science of Persuasion
Scientific American 2001 Feb
http://www.scientificamerican.com/article.cfm?id=the-science-of-persuasion
HSL19888
Skolnick AA.
WHO considers regulating ads, sale of medical products on Internet.
JAMA 1997 3;278:(21):1723-4
http://www.ncbi.nlm.nih.gov/pubmed/9388131
HSL19889
Josefson D.
Bayer made to tone down aspirin advertisements.
West J Med 2000;172:(3):154
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070790/?tool=pubmed
HSL19890
Jaillon P.
The control of prescription drug advertising: a controversial issue.
Clin Pharmacol Ther 2000;68:(6):583-5
http://www.nature.com/clpt/journal/v68/n6/full/clpt2000137a.html
HSL19898
endurance.
In the heartburn wars: speed vs endurance.
Consum Rep 2004;69:(3):49
http://www.ncbi.nlm.nih.gov/pubmed/15005092
HSL19899
McGavock H, Webb CH, Johnston GD, Milligan E.
Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators.
BMJ 1993 30;307:(6912):1118-20
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1679086/?tool=pubmed
HSL19900
Hogerzeil HV, Couper MR, Gray R.
Guidelines for drug donations.
BMJ 1997 8;314:(7082):737-40
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2126144/?tool=pubmed
HSL19903
Schouten E
Drug donations must be strictly regulated. Georgia has tight guidelines.
BMJ 1995 9;311:(7006):684
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551444/?tool=pubmed
HSL19908
Berckmans P, Dawans V, Schmets G, Vandenbergh D, Autier P.
Inappropriate drug-donation practices in Bosnia and Herzegovina, 1992 to 1996.
N Engl J Med 1997 18;337:(25):1842-5
http://www.nejm.org/doi/full/10.1056/NEJM199712183372512
HSL19909
Weir D
Let the Buyer Beware! The New Therapeutic Goods Advertising Code Heralds. Changes in Advertising Medicines.
Health Issues 63 2000 Jun
HSL19920
Metzl J
'Mother's Little Helper': The Crisis of Psychoanalysis and the Miltown Resolution
Gender & History 2003 Aug15:(2):228–255
http://onlinelibrary.wiley.com/doi/10.1111/1468-0424.00300/abstract
HSL19942
Weeks WB, Wallace AE, Kimberly BC
The changing face of pharmaceutical advertising: A look at medical journals reveals a new era in advertising.
Marketing Health Services 2001;27-30
http://www.ncbi.nlm.nih.gov/pubmed/11525138
HSL19943
Davis I.
Inadvertent placement of advertisements.
Med J Aust 1994 6;160:(11):727
http://www.ncbi.nlm.nih.gov/pubmed/8202012
HSL19945
Muldoon C.
Pharmaceutical advertising: fact or fiction?
Pharmacoepidemiol Drug Saf 2004;13:(11):801-2
http://onlinelibrary.wiley.com/doi/10.1002/pds.1011/abstract
HSL19947
Fassold RW, Gowdey CW.
A survey of physicians' reactions to drug promotion.
Can Med Assoc J 1968 6;98:(14):701-5
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924002/?tool=pubmed
HSL19951
Marwick C.
Federal funding for comparative drug studies not in US budget.
BMJ 2004 13;328:(7440):603
http://www.bmj.com/content/328/7440/603.1?view=long&pmid=15016678
HSL19970
Naeem S
Direct promotion to patients?
The Network of Association for Rational Use of Medication in Pakistan 1997 10
HSL19971
Bangash SM
Wrong claims and medical patronage
The Network of Association for Rational Use of Medication in Pakistan 1997
HSL19973
Designing A Prescription Drug Benefit
Health Affairs 2004;23:(1):123
http://content.healthaffairs.org/content/23/1/123.full
HSL19975
Iglehart JK
An Industry Under Siege Mounts Counterattack
Health Affairs 2004 00 00;23:(1):7
http://content.healthaffairs.org/content/23/1/7.full
HSL19982
Hindle D.
Are Australia's drugs too cheap for our own good?
Aust Health Rev 2001;24:(2):4-6
http://www.publish.csiro.au/index.cfm?paper=AH010004
HSL19983
Dalton A.
Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else.
Aust Health Rev 2001;24:(2):7-14
www.publish.csiro.au/index.cfm?paper=AH010007
HSL19985
Viney R.
Funding arrangements for pharmaceuticals: can economic evaluation promote efficiency?
Aust Health Rev 2001;24:(2):21-4
http://www.publish.csiro.au/index.cfm?paper=AH010021
HSL19986
Hartigan-Go K.
The pharmaceutical situation in the Philippines.
Aust Health Rev 2001;24:(2):25-31
http://www.publish.csiro.au/index.cfm?paper=AH010025
HSL19988
Gilsdorf JR.
As drug marketing pays off, my mother pays up.
Health Aff (Millwood) 2004;23:(1):208-12
http://content.healthaffairs.org/content/23/1/208.long
HSL19991
Lenzer J.
Stockholders protest Pfizer's drug prices.
CMAJ 2004 6;171:(1):24
http://www.cmaj.ca/content/171/1/24.2.long
HSL19994
McNamara S
Antidepressant research divides experts
MJA Insight 2012 03 12;(9):
http://www.mjainsight.com.au/view?post=antidepressant-research-divides-experts&post_id=8416&cat=issue-9-12-march-2012
HSL20002
Drug Advertising Wars
Action Network (A Publication of the Australian Pensioners' & Superannuants' Federation 1996 Mar
HSL20004
Lexchin J.
The siren call of new drugs.
Expert Rev Pharmacoecon Outcomes Res 2003;3:(5):513-5
http://www.expert-reviews.com/doi/abs/10.1586/14737167.3.5.513
HSL20006
Dodd P, Dexter T
Reasons for not seeing drug representatives. Companies have to encourage doctors to prescribe their products.
BMJ 1993 9;319:(7215):69-70
http://www.ncbi.nlm.nih.gov/pubmed/10576840
HSL20013
Tiner R
Reasons for not seeing drug representatives: They should be seen because they are a good resource.
BMJ 1999 9;319:(7215):1002
http://www.bmj.com/content/319/7215/1002?view=long&pmid=10514174
HSL20015
Newton-Syms FA, Dawson PH, Cooke J, Feely M, Booth TG, Jerwood D, Calvert RT.
The influence of an academic representative on prescribing by general practitioners.
Br J Clin Pharmacol 1992;33:(1):69-73
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1381201/?tool=pubmed
HSL20025
Lexchin J.
Interactions between doctors and pharmaceutical sales representatives.
Can J Clin Pharmacol 2001;8:(2):64-5
http://www.ncbi.nlm.nih.gov/pubmed/11493932
HSL20031
Preston NW.
Publication bias via suppressed expert conflict.
Lancet 1993 17;341:(8851):1031
http://www.ncbi.nlm.nih.gov/pubmed/8096921
HSL20032
Haynes S
Pharma relationship healthy
Medical Observer 2005 Jan15
HSL20040
Jorm AF.
Gifts from the pharmaceutical industry.
Med J Aust 1997 7;166:(7):386-7
http://www.ncbi.nlm.nih.gov/pubmed/9137287
HSL20041
Goodman B.
All rationalizations large and small.
Am J Bioeth 2003;3:(3):57-8
http://www.tandfonline.com/doi/abs/10.1162/15265160360706624?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
HSL20067
Halperin JA.
Medicine, pharmacy, and industry--a fly's eye view of health care.
Ann Pharmacother 1995;29:(9):925-33
http://www.ncbi.nlm.nih.gov/pubmed/8547743
HSL20068
Huxhagen K
Pharmacy and Drug Companies - An alliance with some problems
Information to Pharmacists 2003 Sep
http://www.computachem.com.au/i2P/emag/Issue19/Article7.shtml
HSL20087
Siegel L
DTC Advertising: Bane...or Blessing?
Pharmaceutical Executive 2000 Oct140-152
http://business.highbeam.com/137364/article-1G1-66355685/dtc-advertising-bane-blessing
HSL20117
Peters J
Hard to swallow: The high cost of direct-to-consumer advertising.
Minnesota Medicine 2001;84:
http://www.ncbi.nlm.nih.gov/pubmed/11202520
HSL20121
DTC ads hotly debated
Pharmacy Today 2001 Jan3, 12
HSL20124
Tudiver S
Advertising Prescription Drugs to Consumers: Why women should be wary of direct advertising of drugs
A Friend Indeed 2001 Mar1-3
http://www.straightgoods.ca/ViewConsForum.cfm?REF=259&Cookies=yes
HSL20125
Advertising Prescription Drugs
Which Online 2001
HSL20128
Panckhurst P
Inside the drug wars
AdMedia 2000 July
http://www.archivesearch.co.nz/?webid=adm&articleid=2983
HSL20148
Hollon MF.
Direct-to-consumer advertising: a haphazard approach to health promotion.
JAMA 2005 27;293:(16):2030-3
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.293.16.2030
HSL20151
McNee W.
More on DTCA and the cost of asthma inhalers.
N Z Med J 2003 7;116:(1185):U673
http://www.ncbi.nlm.nih.gov/pubmed/14615811
HSL20152
Griffiths IJ.
Opponents of DTCA need the objectivity they expect of advertisers.
N Z Med J 2003 10;116:(1183):U641
http://www.ncbi.nlm.nih.gov/pubmed/14581950
HSL20157
Medsafe to report on advert self regulation
Pharmacology Today 2000 Apr8
HSL20158
New legislation
Pharmacy Today 2000 Apr1-2
HSL20160
Medwar C
Because you're worth it
Health Matters Date uncertain 20007
HSL20162
Tsao JC.
Informational and symbolic content of over-the-counter drug advertising on television.
J Drug Educ 1997;27:(2):173-97
http://www.ncbi.nlm.nih.gov/pubmed/9270212
HSL20166
Law J
Preparing to advertise directly to the European consumer
Scrip 1999 Nov6
HSL20179
Collier J.
Conflicts between pharmaceutical company largesse and patients' rights.
Med Leg J 1992;60:
http://www.ncbi.nlm.nih.gov/pubmed/1480006
HSL20188
Gönül FF, Carter F, Wind J.
What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.
Health Care Manag Sci 2000;3:(3):215-26
http://www.ncbi.nlm.nih.gov/pubmed/10907324
HSL20206
Black F.
Teaching rational prescribing.
Aust Fam Physician 1996;25:(7):1097-9
http://www.ncbi.nlm.nih.gov/pubmed/8768276
HSL20207
Bhatt AD.
Drug promotion and doctor: a relationship under change?
J Postgrad Med 1993;39:(3):120-3
http://www.ncbi.nlm.nih.gov/pubmed/8051638
HSL20209
Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA
Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group.
BMJ 1998 15;317:
http://www.bmj.com/content/317/7156/465?view=long&pmid=9703533
HSL20210
Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T.
An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
J Ment Health Policy Econ 2002;5:(1):3-19
http://www.icmpe.net/fulltext.php?volume=5&page=3&year=2002&num=1&name=Berndt%20ER
HSL20211
Bergus GR, Chapman GB, Levy BT, Ely JW, Oppliger RA.
Clinical diagnosis and the order of information.
Med Decis Making 1998;18:(4):412-7
http://mdm.sagepub.com/content/18/4/412.long
Page 204 of 206 pages ‹ First < 202 203 204 205 206 >
